None listed
Conditions
Interventions
Intervention1: CSWRS â?? A: Applied twice daily on face, 6 week sper volunteer
Intervention2: CSWRS â?? B: Applied twice daily on face, 6 weeks per volunteer
Intervention3: CWRS- C: Applied twice dail
Sponsors
ITC RD Centre
Eligibility
Inclusion criteria
Inclusion criteria: • Subject willing to give a written informed consent and come for regular observations • Subject is a healthy adult, male or female, in the age range of 18 and 55 years • Subject has at least 2 and preferably more than 4-5 prominent wrinkles on crow feet area • Subject has at least 2 and preferably more than 4-5 hyperpigmentary spots on face that are freckles, age spots, post inflammatory hyperpigmentation spots like post acne marks, Sebhorreic dermatitis, etc on face • Subject has not participated in a similar clinical investigation in the past three months. • Subject who is willing to abstain from using any fairness product, sunscreens, natural/ ayurvedic treatments or other home remedies and also willing to abstain from undergoing any facial treatments such as facial masks, packs, bleaching, etc either at home or at parlour during the entire study course. In case of having used fairness product in the near past, should be willing to undergo a wash out period of 1 week, wherein they should abstain from applying any product other than the provided cleanser on face. • Male subjects who are willing to maintain their facial skin condition as shaved at baseline and during the entire study course. • Subject who shows no skin sensitivity symptoms to the investigational products during the skin sensitivity test. • Female subjects of reproductive age group should undergo UPT at time of screening visit.
Exclusion criteria
Exclusion criteria: • Subject with a known history or present condition of allergic response to any cosmetic/pharmaceutical products, toiletries or their ingredients including fragrance. • Subject who has used any systemic medication (antibiotics, oral contraceptive pills, retinoids, steroids, spironolactone or any anti acne medication) within past 4 weeks or any topical facial medication within 2 weeks prior to study commencement, which could compromise the study. • Subject with a medical history of disease or condition or a concurrent illness or pre-existing or dormant dermatologic condition (psoriasis, rosacea, rashes, eczema etc.) that could interfere with the study results. • Subject with excessive facial hair or scars, which could interfere with evaluation. • Subject with a history of having used a similar product during or since 1 week prior to the scheduled study commencement. • Subject who is currently pregnant (as confirmed by the urine pregnancy test) or nursing or contemplating pregnancy during the study course. • Subjects viewed by the investigator as not being able to complete the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| study the efficacy of investigational products in reducing hyper pigmentation spots in terms of intensity, size and number in comparison to baseline, comparison to each other. To study the efficacy of investigational products in reducing wrinkle in comparison to baseline. To study the efficacy of investigational products in reducing wrinkle in comparison to each other.Timepoint: Week 1 to Week 6 | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Mukta Sachdev
MS Clinial Research Pvt Ltd
Outcome results
None listed